Cooper Financial Group Purchases 159 Shares of Hologic, Inc. (NASDAQ:HOLX)

Posted by on Mar 23rd, 2023

Cooper Financial Group increased its holdings in shares of Hologic, Inc. (NASDAQ:HOLX – Get Rating) by 3.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,430 shares of the medical equipment provider’s stock after acquiring an additional 159 shares during the period. Cooper Financial Group’s holdings in Hologic were worth $331,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of the business. Utah Retirement Systems grew its holdings in shares of Hologic by 0.5% during the third quarter. Utah Retirement Systems now owns 44,059 shares of the medical equipment provider’s stock worth $2,843,000 after purchasing an additional 200 shares during the last quarter. Bessemer Group Inc. grew its holdings in Hologic by 367.4% during the 3rd quarter. Bessemer Group Inc. now owns 10,812 shares of the medical equipment provider’s stock worth $697,000 after acquiring an additional 8,499 shares during the last quarter. Raymond James Trust N.A. increased its position in Hologic by 10.6% in the 3rd quarter. Raymond James Trust N.A. now owns 8,167 shares of the medical equipment provider’s stock valued at $526,000 after acquiring an additional 783 shares in the last quarter. Allspring Global Investments Holdings LLC raised its stake in shares of Hologic by 101.5% in the third quarter. Allspring Global Investments Holdings LLC now owns 509,298 shares of the medical equipment provider’s stock worth $32,859,000 after acquiring an additional 256,494 shares during the last quarter. Finally, LPL Financial LLC lifted its position in shares of Hologic by 9.1% during the second quarter. LPL Financial LLC now owns 223,823 shares of the medical equipment provider’s stock worth $15,511,000 after purchasing an additional 18,611 shares in the last quarter. 95.17% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, insider Benjamin Jordan Cohn sold 9,128 shares of the stock in a transaction on Tuesday, February 7th. The shares were sold at an average price of $85.28, for a total transaction of $778,435.84. Following the completion of the sale, the insider now owns 14,298 shares of the company’s stock, valued at $1,219,333.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.66% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on HOLX shares. StockNews.com started coverage on shares of Hologic in a report on Thursday, March 16th. They issued a “buy” rating for the company. JPMorgan Chase & Co. boosted their target price on Hologic from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, February 2nd. Wells Fargo & Company raised their price target on Hologic from $75.00 to $80.00 and gave the company an “equal weight” rating in a report on Tuesday, January 10th. SVB Leerink boosted their price objective on Hologic from $90.00 to $93.00 and gave the stock an “outperform” rating in a report on Thursday, February 2nd. Finally, Raymond James raised their target price on shares of Hologic from $80.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, February 2nd. Eight equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $84.08.

Hologic Price Performance

Shares of HOLX stock opened at $78.63 on Thursday. The company has a quick ratio of 3.50, a current ratio of 4.21 and a debt-to-equity ratio of 0.55. Hologic, Inc. has a 12-month low of $59.78 and a 12-month high of $86.65. The firm has a fifty day moving average of $80.98 and a 200-day moving average of $74.32. The firm has a market capitalization of $19.39 billion, a price-to-earnings ratio of 20.06, a price-to-earnings-growth ratio of 1.36 and a beta of 1.01.

Hologic (NASDAQ:HOLX – Get Rating) last posted its earnings results on Wednesday, February 1st. The medical equipment provider reported $1.07 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.17. The firm had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.01 billion. Hologic had a return on equity of 25.12% and a net margin of 22.17%. The company’s revenue for the quarter was down 27.0% on a year-over-year basis. During the same period in the previous year, the company posted $2.17 earnings per share. On average, equities research analysts forecast that Hologic, Inc. will post 3.74 earnings per share for the current year.

Hologic Profile

(Get Rating)

Hologic, Inc engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a portfolio of solutions for breast cancer care for radiology, pathology, and surgery.

Read More

Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX – Get Rating).

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.